Viking Therapeutics (VKTX) Ownership - Who Owns Viking Therapeutics?

7,405 Followers

Viking Therapeutics (VKTX) Ownership Overview

2.88% Insiders

18.14% Mutual Funds

1.18% Other Institutional Investors

12.79% ETFs

65.01% Public Companies and Individual Investors

The ownership structure of Viking Therapeutics (VKTX) stock is a mix of institutional, retail, and individual investors. Approximately 32.11% of the company’s stock is owned by Institutional Investors, 2.88% is owned by Insiders, and 65.01% is owned by Public Companies and Individual Investors.

The ownership structure of Viking Therapeutics (VKTX) stock is a mix of institutional, retail, and individual investors. Approximately 19.32% of the company’s stock is owned by Institutional Investors, 2.88% is owned by Insiders, and 12.79% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Mar 10, 2026	Neil William Aubuchon	xxxxxxxxxxxxx	$149913
Jan 05, 2026	Brian Lian	xxxxxxxxxxxxx	$7691296
Jan 05, 2026	Matthew W. Foehr	xxxxxxxxxxxxx	$561600
Jan 05, 2026	Greg Zante	xxxxxxxxxxxxx	$1896692

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Dec 31, 2023	Bridgewater Associates, Lp	xxxxxxxxxxxxx	$3646724
Dec 31, 2023	Soros Fund Mangment Llc	xxxxxxxxxxxxx	$3166200
Dec 31, 2023	Woodline Partners Lp	xxxxxxxxxxxxx	$10625486
Dec 31, 2023	Goalvest Advisory Llc	xxxxxxxxxxxxx	$5277

Show More Hedge Fund Trading Activity >

Top Shareholders

# of Shares	Type	% Holding	Value
9,207,650	Institution	7.94%	288,475,675
8,408,937	Institution	7.26%	263,451,996
2,641,954	Institution	2.28%	82,772,419
2,499,291	Insider	2.16%	78,302,787
1,483,560	Institution	1.28%	46,479,935
1,259,263	Institution	1.09%	39,452,710
1,251,364	Institution	1.08%	39,205,234
1,145,823	Institution	0.99%	35,898,635
1,068,557	Institution	0.92%	33,477,891
997,387	Institution	0.86%	31,248,135

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
8,408,937	Institution	7.26%	263,451,996
1,259,263	Institution	1.09%	39,452,710
1,251,364	Institution	1.08%	39,205,234
1,145,823	Institution	0.99%	35,898,635
1,068,557	Institution	0.92%	33,477,891
997,387	Institution	0.86%	31,248,135
996,435	Institution	0.86%	31,218,309
782,196	Institution	0.67%	24,506,201
604,745	Institution	0.52%	18,946,661
568,044	Institution	0.49%	17,796,819

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	3,507,697	Institution	3.03%	114,140,460
SPDR S&P BIOTECH ETF	2,654,706	Institution	2.29%	85,985,927
Vanguard Small-Cap ETF	2,536,538	Institution	2.19%	82,538,947
Vanguard Small-Cap Growth ETF	1,421,836	Institution	1.23%	46,266,543
Vanguard Extended Market ETF	1,291,889	Institution	1.11%	42,038,068
Schwab U.S. Small-Cap ETF	562,439	Institution	0.49%	18,217,399
iShares Russell Midcap ETF	425,704	Institution	0.37%	13,337,306
Vanguard Health Care ETF	321,562	Institution	0.28%	10,463,627
iShares Russell 1000 Value ETF	224,971	Institution	0.19%	7,048,341
iShares Core S&P Total U.S. Stock Market ETF	155,425	Institution	0.13%	5,034,216

FAQ

Who Owns Viking Therapeutics (VKTX)?

According to the latest TipRanks data, approximately 1.18% of the company's stock is held by institutional investors, 2.88% is held by insiders, and 65.01% is held by retail investors.

What percentage of Viking Therapeutics (VKTX) stock is held by institutional investors?

According to the latest TipRanks data, approximately 1.18% of Viking Therapeutics (VKTX) stock is held by institutional investors.

What percentage of Viking Therapeutics (VKTX) stock is held by retail investors?

According to the latest TipRanks data, approximately 65.01% of Viking Therapeutics (VKTX) stock is held by retail investors.

Who owns the most shares of Viking Therapeutics (VKTX)?

Vanguard owns the most shares of Viking Therapeutics (VKTX).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.